Literature DB >> 33221901

Incidence, epidemiology, diagnosis and prognosis of atrio-oesophageal fistula following percutaneous catheter ablation: a French nationwide survey.

Estelle Gandjbakhch1, Franck Mandel2, Yann Dagher1, Francoise Hidden-Lucet1, Anne Rollin2, Philippe Maury2,3.   

Abstract

AIMS: Rate, incidence, risk factors, and optimal management of atrio-oesophageal fistula (AOF) after catheter ablation for atrial fibrillation (AF) remain obscure. METHODS AND
RESULTS: All French centres performing AF ablation were identified and surveys were sent concerning the number of procedures, eventual cases of AOF, and characteristics of such cases. Eighty-two of the 103 centres (80%) performing AF ablation in France were included, with a total of 129 286 AF ablations since 2006 (93% of the whole procedures in France). Thirty-three AOF were reported (reported rate 0.026% per procedure) with a stable reported annual incidence despite the increasing number of procedures. Sensitivity of computed tomography (CT) scan for AOF was 81%. Mortality was 60%, significantly lower in case of surgical corrective therapy (31 vs. 93%, P = 0.001).
CONCLUSION: The reported rate of AOF after AF ablation in this nationwide survey was 0.026%, with a stable reported annual incidence over time. A normal CT scan does not rule out the diagnosis and should be repeated in case of suspicion. Prognosis remains poor with a mortality of 60% and crucially dependant of immediate surgical correction. No clear protective strategy has been proven effective. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Atrio-oesophageal fistula; Complications; Epidemiology; Prognosis

Year:  2021        PMID: 33221901     DOI: 10.1093/europace/euaa278

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  7 in total

1.  Preventing esophageal complications from atrial fibrillation ablation: A review.

Authors:  Lisa W M Leung; Zaki Akhtar; Mary N Sheppard; John Louis-Auguste; Jamal Hayat; Mark M Gallagher
Journal:  Heart Rhythm O2       Date:  2021-09-22

2.  Radiofrequency ablation data associated with atrioesophageal fistula.

Authors:  David R Tomlinson; John Mandrola
Journal:  HeartRhythm Case Rep       Date:  2021-12-15

Review 3.  Protecting Against Collateral Damage to Non-cardiac Structures During Endocardial Ablation for Persistent Atrial Fibrillation.

Authors:  Lisa Wm Leung; Zaki Akhtar; Jamal Hayat; Mark M Gallagher
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04

4.  Epicardial Radiofrequency Ablation for Ventricular Tachycardia: Old Techniques, New Risks?

Authors:  Sofian Johar
Journal:  JACC Case Rep       Date:  2022-09-21

5.  Asymptomatic left circumflex artery stenosis is associated with higher arrhythmia recurrence after persistent atrial fibrillation ablation.

Authors:  Rodrigue Garcia; Mathilde Clouard; Fabian Plank; Bruno Degand; Séverine Philibert; Gabriel Laurent; Pierre Poupin; Saliman Sakhy; Matthieu Gras; Markus Stühlinger; Nándor Szegedi; Szilvia Herczeg; Judit Simon; Harry J G M Crijns; Eloi Marijon; Luc Christiaens; Charles Guenancia
Journal:  Front Cardiovasc Med       Date:  2022-09-26

6.  Virtual Reality for Sedation During Atrial Fibrillation Ablation in Clinical Practice: Observational Study.

Authors:  Thomas Roxburgh; Anthony Li; Charles Guenancia; Patrice Pernollet; Claire Bouleti; Benjamin Alos; Matthieu Gras; Thomas Kerforne; Denis Frasca; François Le Gal; Luc Christiaens; Bruno Degand; Rodrigue Garcia
Journal:  J Med Internet Res       Date:  2021-05-27       Impact factor: 5.428

7.  Atrio-oesophageal fistula following atrial fibrillation ablation: how to manage this dreaded complication?

Authors:  Alexander Moiroux-Sahraoui; Gilles Manceau; Thibaut Schoell; Alain Combes; Adrien Bouglé; Pascal Leprince; Jean Christophe Vaillant; Guillaume Lebreton
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-11-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.